An interventional study of MiSight contact lenses and Proclear contact lenses in Myopia, Progressive, sponsored by University of Bradford. Enrolling by invitation at 2 sites in United Kingdom. Open to participants aged 18 Years to 21 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-23.
Sponsored by University of Bradford · Not applicable, Interventional, and Treatment
The purpose of the study is to quantify the effectiveness of Coopervision MiSight contact lenses in slowing the rate of myopia progression in university students.
MiSight contact lenses have been shown to be a safe and effective way of managing myopia progression in children aged 8-12 years. However, myopic progression is not limited to children of this age group and MiSight lenses have also been shown to be effective in older children aged 11-16 years. There is evidence that progression also occurs in university students. The researchers are therefore investigating the effectiveness of this intervention in a group of UK-based University students.
71 studies on the registry are indexed under Myopia, Degenerative; 20 are open to participants now.
This study's planned enrollment of 84 is below the median of 122 across 57 interventional studies indexed under Myopia, Degenerative.
Browse Myopia, Degenerative studies →University of Bradford is the lead sponsor of 6 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Device: MiSight contact lenses
Device: Proclear contact lenses
Contact lens for myopia management.
Single vision contact lens as control
Change in axial length relative to baseline
Time frame: Baseline, 24 months
Change in spherical equivalent cycloplegic autorefraction relative to baseline
Time frame: Baseline, 24 months
Plan to share: Undecided
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Bradford